Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Goldman Sachs Group Inc (GS) vs Tilray Brands Inc (TLRY) Price & Performance

Goldman Sachs Group IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Goldman Sachs Group Inc vs Tilray Brands Inc — how do they compare? Goldman Sachs Group Inc trades at $1,037.45 (market cap $301.22B), while Tilray Brands Inc trades at $4.75 (market cap $601.34M). The key difference: Goldman Sachs Group Inc is far larger — about 500.9× Tilray Brands Inc's market cap, and Goldman Sachs Group Inc pays a 1.93% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

GSTLRY
Market Cap
$301.22B$601.34M
Volume
2,592,735
Sector
FinancialsHealth
52-Week High
$1.15K$21.00
52-Week Low
$715.95$3.88
Dividend Yield
1.93%
Enterprise Value
$768.47M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Goldman Sachs Group Inc

Goldman Sachs (GS) trades at $1,034.41, down 0.5% on the day, with a neutral technical signal. The company shows strong fundamental momentum with three consecutive quarterly EPS beats and revenue growth accelerating to $58.3B in 2025. Analyst consensus is mixed with 40% buy ratings but a $1,160 price target suggesting 12% upside potential. Recent news highlights Goldman's leadership role in major upcoming IPOs including Anthropic, SpaceX, and OpenAI.

The outlook remains positive given Goldman's positioning in the upcoming AI IPO wave and strong investment banking pipeline. Key risks include volatile cash flow patterns with negative operating cash flow in recent periods and market sensitivity to interest rate changes. The stock appears reasonably valued at 16x P/E with 31.7% net margins supporting further upside if earnings momentum continues.

Tilray Brands Inc

TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.

Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Goldman Sachs Group Inc

The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.

Read more on GS

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY